Procalcitonin-guided treatment of lower respiratory tract infections

被引：0

作者：

Watkins, Elyse J. ^{[1
]}

Guerrini, James ^{[2
]}

机构：

[1] High Point NC Univ, High Point, NC 27262 USA

[2] Wake Forest Baptist Hlth, Urgent Care, Winston Salem, NC USA

来源：

JAAPA-JOURNAL OF THE AMERICAN ACADEMY OF PHYSICIAN ASSISTANTS | 2018年 / 31卷 / 01期

关键词：

procalcitonin; sepsis; lower respiratory tract infections; antibiotics; multidrug-resistant; assay; ANTIBIOTIC USE;

D O I：

10.1097/01.JAA.0000527711.69310.ae

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

The FDA recently approved a procalcitonin assay for use in hospitals and EDs to help prescribers determine if an antibiotic should be prescribed and for what duration. This article reviews the use of procalcitonin testing and evidence-based medical decision-making for patients with sepsis or lower respiratory tract infections.

引用

页码：50 / 52

页数：3

共 50 条

[21] Using procalcitonin-guided algorithms to improve antimicrobial therapy in ICU patients with respiratory infections and sepsis
Schuetz, Philipp
Raad, Issam
Amin, Devendra N.
CURRENT OPINION IN CRITICAL CARE, 2013, 19 (05) : 453 - 460
[22] Effect of Procalcitonin-Guided Treatment in Patients with Infections: a Systematic Review and Meta-Analysis
H. Tang
T. Huang
J. Jing
H. Shen
W. Cui
Infection, 2009, 37 : 497 - 507
[23] Procalcitonin-Based Guidelines and Lower Respiratory Tract Infections Reply
Schuetz, Philipp
Zimmerli, Werner
Mueller, Beat
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2010, 303 (05): : 419 - 420
[24] Effect of Procalcitonin-Guided Treatment in Patients with Infections: a Systematic Review and Meta-Analysis
Tang, H.
Huang, T.
Jing, J.
Shen, H.
Cui, W.
INFECTION, 2009, 37 (06) : 497 - 507
[25] Procalcitonin importance in monitoring and prognosis of lower respiratory tract infections in children
Larisa, Horga Adeline
EUROPEAN JOURNAL OF PEDIATRICS, 2017, 176 (11) : 1551 - 1551
[26] Procalcitonin-guided antibiotic therapy in patients with congestive heart failure and suspicion of lower respiratory tract infection: results from a randomized trial
P Schuetz
E Grolimund
A Kutz
S Haubitz
B Mueller
Critical Care, 17 (Suppl 2):
[27] Markers of acute inflammation in assessing and managing lower respiratory tract infections:: focus on procalcitonin
Mueller, B.
Prat, C.
CLINICAL MICROBIOLOGY AND INFECTION, 2006, 12 : 8 - 16
[28] Antibiotic treatment interruption of suspected lower respiratory tract infections based on a single procalcitonin measurement at hospital admission-a randomized trial
Kristoffersen, K. B.
Sogaard, O. S.
Wejse, C.
Black, F. T.
Greve, T.
Tarp, B.
Storgaard, M.
Sodemann, M.
CLINICAL MICROBIOLOGY AND INFECTION, 2009, 15 (05) : 481 - 487
[29] Procalcitonin-guided antibiotic therapy algorithms for different types of acute respiratory infections based on previous trials
Schuetz, Philipp
Bolliger, Rebekka
Merker, Meret
Christ-Crain, Mirjam
Stolz, Daiana
Tamm, Michael
Luyt, Charles E.
Wolff, Michel
Schroeder, Stefan
Nobre, Vandack
Reinhart, Konrad
Branche, Angela
Damas, Pierre
Nijsten, Maarten
Deliberato, Rodrigo O.
Verduri, Alessia
Beghe, Bianca
Cao, Bin
Shehabi, Yahya
Jensen, Jens-Ulrik S.
Beishuizen, Albertus
de Jong, Evelien
Briel, Matthias
Welte, Tobias
Mueller, Beat
EXPERT REVIEW OF ANTI-INFECTIVE THERAPY, 2018, 16 (07) : 555 - 564
[30] Economic evaluation of procalcitonin-guided antibiotic therapy in acute respiratory infections: a US health system perspective
Schuetz, Philipp
Balk, Robert
Briel, Matthias
Kutz, Alexander
Christ-Crain, Mirjam
Stolz, Daiana
Bouadma, Lila
Wolff, Michel
Kristoffersen, Kristina B.
Wei, Long
Burkhardt, Olaf
Welte, Tobias
Schroeder, Stefan
Nobre, Vandack
Tamm, Michael
Bhatnagar, Neera
Bucher, Heiner C.
Luyt, Charles-Edouard
Chastre, Jean
Tubach, Florence
Mueller, Beat
Lacey, Michael J.
Ohsfeldt, Robert L.
Scheibling, Cara M.
Schneider, John E.
CLINICAL CHEMISTRY AND LABORATORY MEDICINE, 2015, 53 (04) : 583 - 592

← 1 2 3 4 5 →